These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31571451)

  • 1. Factors Differentiating Acute Hepatitis B from Acute Exacerbation of Chronic Hepatitis B in Prospective-retrospective Cohort.
    Thanage R; Rathi P; Pawar V; Udgirkar S; Jain S; Contractor Q; Chandnani S; Junare P
    J Assoc Physicians India; 2019 Oct; 67(10):39-43. PubMed ID: 31571451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.
    Han Y; Tang Q; Zhu W; Zhang X; You L
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1728-33. PubMed ID: 18823435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of acute and chronic hepatitis B in IgM anti-HBc positive patients.
    Park JW; Kwak KM; Kim SE; Jang MK; Kim DJ; Lee MS; Kim HS; Park CK
    World J Gastroenterol; 2015 Apr; 21(13):3953-9. PubMed ID: 25852281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.
    Puri P
    J Clin Exp Hepatol; 2013 Dec; 3(4):301-12. PubMed ID: 25755518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?
    Lall S; Agarwala P; Kumar G; Sharma MK; Gupta E
    Clin Mol Hepatol; 2020 Apr; 26(2):187-195. PubMed ID: 32272817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Hepatitis B Core Antigen Antibody, a Quantitative Non-Invasive Marker of Hepatitis B Virus Induced Liver Disease.
    Yuan Q; Song LW; Cavallone D; Moriconi F; Cherubini B; Colombatto P; Oliveri F; Coco BA; Ricco G; Bonino F; Shih JW; Xia NS; Brunetto MR
    PLoS One; 2015; 10(6):e0130209. PubMed ID: 26115521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.
    Oliveri F; Surace L; Cavallone D; Colombatto P; Ricco G; Salvati N; Coco B; Romagnoli V; Gattai R; Salvati A; Moriconi F; Yuan Q; Bonino F; Brunetto MR
    Liver Int; 2017 Nov; 37(11):1622-1631. PubMed ID: 28296013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
    Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating acute hepatitis B from the first episode of symptomatic exacerbation of chronic hepatitis B.
    Kumar M; Jain S; Sharma BC; Sarin SK
    Dig Dis Sci; 2006 Mar; 51(3):594-9. PubMed ID: 16614972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hepatitis B core antibody titer use in screening for significant fibrosis in treatment-naïve patients with chronic hepatitis B.
    Li MR; Zheng HW; Lu JH; Ma SM; Ye LH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH; Sun DX
    Oncotarget; 2017 Feb; 8(7):11063-11070. PubMed ID: 28052021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression signatures of peripheral CD4+ T cells clearly discriminate between patients with acute and chronic hepatitis B infection.
    TrehanPati N; Geffers R; Sukriti ; Hissar S; Riese P; Toepfer T; Buer J; Kumar M; Guzman CA; Sarin SK
    Hepatology; 2009 Mar; 49(3):781-90. PubMed ID: 19185001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study.
    Jia W; Song LW; Fang YQ; Wu XF; Liu DY; Xu C; Wang XM; Wang W; Lv DX; Li J; Deng YQ; Wang Y; Huo N; Yu M; Xi HL; Liu D; Zhou YX; Wang GQ; Xia NS; Zhang MX
    Medicine (Baltimore); 2014 Dec; 93(29):e322. PubMed ID: 25546679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels.
    Dao DY; Hynan LS; Yuan HJ; Sanders C; Balko J; Attar N; Lok AS; Word RA; Lee WM;
    Hepatology; 2012 Mar; 55(3):676-84. PubMed ID: 21987355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative hepatitis B core antibody level is associated with inflammatory activity in treatment-naïve chronic hepatitis B patients.
    Li MR; Lu JH; Ye LH; Sun XL; Zheng YH; Liu ZQ; Zhang HC; Liu YY; Lv Y; Huang Y; Dai EH
    Medicine (Baltimore); 2016 Aug; 95(34):e4422. PubMed ID: 27559949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A retrospective study of clinical and pathological spectrum in 91 patients with chronic severe hepatitis B].
    Liu XH; Zheng SJ; Zu KJ; Chen Y; Chen YS; Wang TL; Duan ZP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Oct; 18(10):721-5. PubMed ID: 21059285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection.
    Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK
    Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.
    Assy N; Beniashvili Z; Djibre A; Nasser G; Grosovski M; Nseir W
    World J Gastroenterol; 2009 Jun; 15(24):3025-31. PubMed ID: 19554656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of anti-HBc quantification in hepatitis B virus related acute-on-chronic liver failure.
    Li J; Gong QM; Xie PL; Lin JY; Chen J; Wei D; Yu DM; Han Y; Zhang XX
    J Gastroenterol Hepatol; 2021 May; 36(5):1291-1299. PubMed ID: 33091955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
    Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
    J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between serum hepatitis B surface antigen and hepatitis B core antibody titers and liver fibrosis in treatment-naïve CHB patients.
    Li MR; Zheng HW; Ma SM; Liu YY; Qie LX; Li JQ; Wang DH; Sun XL; Ren GF; Zheng YH; Wang YL; Dai EH
    J Chin Med Assoc; 2018 Dec; 81(12):1052-1059. PubMed ID: 30143430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.